Peroxidative modification of very-low-density lipoproteins in chronic hemodialysis patients.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Nephron

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000187189PMID 8450918
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biotinyl-high-density lipoproteins as a probe for the determination of high-density lipoprotein turnover in humans.

  1990cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct.

  1987cited by this paper
• Lipid Research Clinics Coronary Primary Prevention Trial results.

  1985cited by this paper
• Survival rates of 2,728 patients with end-stage renal disease.

  1984cited by this paper
• Lipid Research Clinics Coronary Primary Prevention Trial Results

  1984cited by this paper
• Quantitation of the transfer of surface phospholipid of chylomicrons to the high density lipoprotein fraction during the catabolism of chylomicrons in the rat.

  1979cited by this paper
• Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method.

  1978cited by this paper
• Hypertriglyceridemia in chronic nonnephrotic renal failure.

  1973cited by this paper
• The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters.

  1962cited by this paper
• The thiobarbituric acid assay of sialic acids.

  1959cited by this paper

• Lipids and atherosclerosis

  2004cites this paper
• Section VII. Vascular disease and risk factors.

  2002cites this paper
• Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.

  2000cites this paper
• Volatile Alkanes and Increased Concentrations of Isoprene in Exhaled Air during Hemodialysis

  1999cites this paper
• Causes of Coronary Heart Disease in Patients on Renal Replacement Therapy

  1998cites this paper
• Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients.

  1997cites this paper
• Atherosclerosis and arteriosclerosis in chronic renal failure.

  1997cites this paper
• No direct evidence of increased lipid peroxidation in hemodialysis patients.

  1996cites this paper
• Does the modality of haemodialysis treatment affect lipoprotein composition?

  1996cites this paper
• Organ and Metabolic Complications: Lipids/Atherosclerosis

  1996cites this paper
• Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment.

  1995cites this paper
• Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility?

  1994cites this paper